• Fri. Jan 28th, 2022

Cardiac Surgery: Corcym, a company of cardiological devices makes its global debut

Byeditorial

Jun 1, 2021

Corcym, a new independent medical device company entirely dedicated to supporting cardiac surgeons with the best solutions for structural heart disease, today announces the start of operations globally. Born from the acquisition of the heart valve business of LivaNova Plc (LivaNova) by Gyrus Capital (Gyrus), an investment fund operating in the health and sustainability sectors, Corcym – reports a note – enters the market with a broad portfolio of products for cardiac surgeons and their patients around the world. “We are delighted to announce the birth of Corcym globally,” comments Christian Mazzi, CEO of the company. “We enter the market today with a solid legacy and a consolidated product portfolio over more than 50 years. Our commitment is to become the reference point for cardiac surgeons and their patients. “The name of the new company – from the Latin Cor (heart) and Cym (Cymbalon, valve) – expresses its focus: supporting cardiac surgeons with the best solutions for structural heart diseases. Corcym is present in over 100 countries, with two main production sites in Saluggia, Italy, and Burnaby, Canada, and about 850 employees. “Our mission – underlines Mazzi – is to help cardiac surgeons to better care for patients, today and in the future. Our plan is to enhance our foundations in mechanical valves and fuel growth with our two product platforms Perceval® and Memo, as well as investing in research to develop new products and new collaborations. We have created Corcym as an agile, dedicated, customer-focused company and we have the support of Gyrus, a solid partner with an industry focus, ready to invest in our future ”. Clinical evidence will play a vital role in the future of Corcym’s heart valve technologies. The company will support a vibrant clinical program, in partnership with leading cardiac surgery professionals, to develop clinical trials and support their initiatives. Corcym also – concludes the company note – will continue and expand the training and training programs related to its devices.

One thought on “Cardiac Surgery: Corcym, a company of cardiological devices makes its global debut”
  1. editorial says:

    https://created.crayola.com/network/members/profile?UserKey=be01f867-ad1e-4507-a078-481dea7734db
    https://created.crayola.com/network/members/profile?UserKey=8b02d78b-b4e6-4e19-93a4-a34f0d38ef31
    https://created.crayola.com/network/members/profile?UserKey=7bdef096-169a-4de9-a5c2-d7381b3b2eec
    https://created.crayola.com/network/members/profile?UserKey=972f2404-c1c9-4cab-8af7-1ff23c6187e4
    https://created.crayola.com/network/members/profile?UserKey=d075e24f-058c-451a-b90e-4157370bc4de
    https://created.crayola.com/network/members/profile?UserKey=51845052-8295-4c51-a9a1-a16bfa9e18d2
    https://created.crayola.com/network/members/profile?UserKey=8f1bd077-35a8-455c-b72f-b8be031902eb
    https://created.crayola.com/network/members/profile?UserKey=1fd3f71f-858f-4d32-b7ba-ad526d7b4b60
    https://connect.informs.org/network/members/profile?UserKey=e0c73c58-df23-4959-a032-734a273c853d
    https://connect.informs.org/network/members/profile?UserKey=e0e500ce-a9db-47ba-82bb-7ebd31ad866d
    https://connect.informs.org/network/members/profile?UserKey=d2841544-207a-49f8-9c35-9ec14524529d
    https://connect.informs.org/network/members/profile?UserKey=7a430697-5301-48b6-9e65-97efbae6a2a2
    https://connect.informs.org/network/members/profile?UserKey=1fcc88d1-8906-4684-abdb-66b7d2e268b6
    https://connect.informs.org/network/members/profile?UserKey=8910a70e-af1c-42f5-be65-425abf4b67e1
    https://connect.informs.org/network/members/profile?UserKey=76fc4320-6d0e-4c0d-bf81-d479bf7b934d
    https://connect.informs.org/network/members/profile?UserKey=49a97aa4-dca9-46e4-976f-d991a2629f11
    https://connect.informs.org/network/members/profile?UserKey=12bff438-6b22-4383-a0a9-218806c45e66
    https://connect.informs.org/network/members/profile?UserKey=125c0b7e-695a-4a2d-be3f-6791199dd771
    https://connect.informs.org/network/members/profile?UserKey=b2cc5756-48d9-4ec1-b154-5f3ed9fbeb47
    https://connect.informs.org/network/members/profile?UserKey=9bc5dc06-e41c-4699-98e8-e56f130ffc11
    https://connect.informs.org/network/members/profile?UserKey=41c778a3-97a4-4dab-b0fd-b7c9c286d4d0
    https://connect.informs.org/network/members/profile?UserKey=22401a13-77b6-4d4b-acef-27d501912cdb
    https://connect.informs.org/network/members/profile?UserKey=83880a38-41da-4c24-9ad9-0842fd230c89
    https://connect.informs.org/network/members/profile?UserKey=946e6778-e7be-4a05-8fc9-c03a57dd2b6a
    https://connect.informs.org/network/members/profile?UserKey=355455a8-c1ce-4f62-89e6-00a97ee21d79
    https://connect.informs.org/network/members/profile?UserKey=f4aef491-c1ae-46da-b506-90183ea77b96
    https://connect.informs.org/network/members/profile?UserKey=b609ff95-78b2-42bf-a1df-723bf0f6ecd8
    https://connect.informs.org/network/members/profile?UserKey=3c8c4a11-1501-411d-b927-370d81d22e3c
    https://connect.informs.org/network/members/profile?UserKey=ca9f4fed-00c4-4fcc-9b90-3df3edc965fe
    https://connect.informs.org/network/members/profile?UserKey=a1f3d220-7303-4063-ba9c-883cd618dd69
    https://connect.informs.org/network/members/profile?UserKey=67e15723-f86d-423f-a9fa-8235e72aae96
    https://connect.informs.org/network/members/profile?UserKey=8ff55740-2c65-4211-a85b-4bb3660783de
    https://connect.informs.org/network/members/profile?UserKey=7edc317e-4516-4094-b2e5-db80c0948304
    https://connect.informs.org/network/members/profile?UserKey=2dbca192-eae6-4857-92fb-10e2b61a2034
    https://connect.informs.org/network/members/profile?UserKey=7dc16f44-47ec-47ec-9bf8-ad5c86e2c700
    https://connect.informs.org/network/members/profile?UserKey=2277d174-79ef-4afb-bc96-76672e03e296
    https://connect.informs.org/network/members/profile?UserKey=a33b714d-42b6-4301-8c0e-d8585d54bda0
    https://connect.informs.org/network/members/profile?UserKey=f2e9c7fb-5e26-4dcd-8e66-69d4975d1ebf
    https://connect.informs.org/network/members/profile?UserKey=a379e198-64f5-466b-9841-da230efb2cbf
    https://connect.informs.org/network/members/profile?UserKey=ad68a2ff-06d2-400e-9f31-983167fdeb71
    https://connect.informs.org/network/members/profile?UserKey=0241fc39-499b-4b35-b58e-c24a046b2606
    https://connect.informs.org/network/members/profile?UserKey=2ccfefb3-65d6-41d1-88cc-9911b3f0a53e
    https://connect.informs.org/network/members/profile?UserKey=e01f694b-0781-423b-835b-8e89fff35495
    https://connect.informs.org/network/members/profile?UserKey=b9033ddd-119f-4f16-b27b-04e971d132a3
    https://connect.informs.org/network/members/profile?UserKey=27cca9c3-384c-46fd-b3d9-91f1e358e0bc
    https://connect.informs.org/network/members/profile?UserKey=a625b7b4-b336-49e9-9e08-460444ee2346
    https://connect.informs.org/network/members/profile?UserKey=e42f37f6-bf82-4c12-9033-3f438448ec8a
    https://connect.informs.org/network/members/profile?UserKey=88a8f610-f02b-47eb-a292-854b6e1cd4ad
    https://connect.informs.org/network/members/profile?UserKey=ff164cb0-c737-4dda-b52d-f6bc93aa3578
    https://connect.informs.org/network/members/profile?UserKey=b8ae7991-9698-4870-8449-55eaa2a92b7c

Comments are closed.